IgM nephropathy
A kidney disorder characterized by the presence of IgM antibodies in the glomeruli
IgM nephropathy is a kidney disorder characterized by the presence of immunoglobulin M (IgM) antibodies in the glomeruli, which are the filtering units of the kidney. This condition is considered a form of glomerulonephritis, a group of diseases that cause inflammation of the glomeruli.
Pathophysiology[edit | edit source]
IgM nephropathy is marked by the deposition of IgM antibodies in the mesangial areas of the glomeruli. The exact mechanism by which IgM contributes to kidney damage is not fully understood. However, it is believed that the presence of IgM may activate the complement system, leading to inflammation and damage to the glomerular structure. This can result in impaired kidney function and proteinuria, where excess protein is found in the urine.
Clinical Presentation[edit | edit source]
Patients with IgM nephropathy may present with a variety of symptoms, including:
- Proteinuria
- Hematuria
- Hypertension
- Edema
The severity of symptoms can vary widely among individuals. Some patients may have mild symptoms, while others may progress to more severe kidney damage.
Diagnosis[edit | edit source]
The diagnosis of IgM nephropathy is typically made through a kidney biopsy. Under a microscope, the biopsy will show mesangial deposits of IgM antibodies. Immunofluorescence microscopy is often used to confirm the presence of IgM in the glomeruli.
Treatment[edit | edit source]
Treatment for IgM nephropathy is not standardized and can vary depending on the severity of the disease. Common approaches include:
- Corticosteroids to reduce inflammation
- Immunosuppressive drugs
- Angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin II receptor blockers (ARBs) to control blood pressure and reduce proteinuria
Prognosis[edit | edit source]
The prognosis for patients with IgM nephropathy varies. Some individuals may experience a benign course with minimal kidney damage, while others may progress to chronic kidney disease or even end-stage renal disease. Regular monitoring and management of symptoms are crucial to improving outcomes.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
